English | Español

Eli Lilly And Company
Carol Ostrow | Oct 14, 2017

Lilly wins right to patent Alimta vitamin treatment for certain lung cancers
Carrie Bradon | Sep 21, 2017

Oncology Data Network called key to improving health care in Europe
Carol Ostrow | Sep 20, 2017

Lilly study supports Cyramza (ramucirumab) efficacy for treating urothelial carcinoma
Carrie Bradon | Jul 9, 2017

Japanese Ministry of Health, Labor and Welfare approves Olumiant
Erianne Leatherman | Jun 21, 2017

Lilly says its galcanezumab cuts down on amount of migraine headache days

Ruth de Jauregui | Jun 14, 2017

Boehringer Ingelheim, Eli Lilly to collaborate in trial of empagliflozin for chronic kidney disease
Robert Hadley | Jun 14, 2017

Eli Lilly anti-cancer drug may halt breast cancer spread when paired with fulvestrant
Ruth de Jauregui | May 21, 2017

Lilly says studies show galcanezumab can reduce migraine episodes

Trending
+ Technology/Innovation
Patient Daily | May 8, 2025

Medfluence attends 2025 Annual Clinical Assembly as only strategic marketing firm
+ Technology/Innovation
Patient Daily | May 7, 2025

OTO Forum 2025 highlights innovation in ENT
+ Pharmaceuticals
Patient Daily | May 8, 2025

Pacific Research Institute CEO: Hospitals are leveraging 340B's 'perverse incentives to enrich themselves'
+ Pharmaceuticals
Patient Daily | May 8, 2025

National Library of Medicine says compounded drugs like GLP-1 offer tailored alternatives to FDA-approved treatments